suggested that chronic liver diseases could be associated with reduced ADAMTS13 activity, and defective ADAMTS13 synthesis could be a consequence of liver inflammation, as seen in NASH. Here, ADAMTS13 is linked to metabolic dysfunction-associated steatohepatitis.